The Future of HIV-1 Therapeutics [electronic resource] Resistance Is Futile? / edited by Bruce E. Torbett, David S. Goodsell, Douglas D. Richman.

This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce...

Full description

Bibliographic Details
Uniform Title:Current Topics in Microbiology and Immunology, 2196-9965 ; 389
Corporate Author: SpringerLink (Online service)
Other Authors: Torbett, Bruce E. (Editor)
Goodsell, David S. (Editor)
Richman, Douglas D. (Editor)
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2015.
Edition:1st ed. 2015.
Series:Current Topics in Microbiology and Immunology, 389
Subjects:
Medical microbiology.
Virology.
Diseases.
Online Access:
Springer English/International eBooks 2015 - Full Set: 2015 (Springer Link)
Variant Title:
Future of Hiv-1 Therapeutics: Resistance is Futile?
Format: Electronic eBook
Contents:
  • HIV Therapy ­ Looking Towards the Future
  • Computational challenges of structure-based approaches applied to HIV
  • Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1
  • HIV-1 integrase multimerization as a therapeutic target
  • Targeting HIV transcription: The quest for a functional cure
  • Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder
  • HIV-1 Gag: An Emerging Target for Antiretroviral Therapy
  • The Triple Threat of HIV-1 Protease Inhibitors
  • Illustrations of the HIV Life Cycle.